High water vs. ad libitum water intake for autosomal dominant polycystic kidney disease: a randomized controlled feasibility trial
QJM
.
2020 Apr 1;113(4):306.
doi: 10.1093/qjmed/hcz326.
Authors
R El-Damanawi
1
2
,
M Lee
3
,
T Harris
4
,
L B Cowley
2
5
,
S Bond
2
,
H Pavey
2
,
R N Sandford
6
,
I B Wilkinson
1
2
,
F E Karet Frankl
6
,
T F Hiemstra
1
2
Affiliations
1
Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge.
2
Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
3
Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge.
4
PKD Charity, 91 Royal College, London.
5
Patient Led Research Hub, Cambridge NIHR Biomedical Research Centre, Cambridge.
6
Department of Medical Genetics, University of Cambridge, Hills Road, Cambridge, UK.
PMID:
31956915
PMCID:
PMC7133781
DOI:
10.1093/qjmed/hcz326
No abstract available
Publication types
Published Erratum